TC-E 5003, a protein methyltransferase 1 inhibitor, activates the PKA-dependent thermogenic pathway in primary murine and human subcutaneous adipocytes

  • FEBS Lett. 2020 Sep;594(17):2923-2930. doi: 10.1002/1873-3468.13900.
Min-Jung Park  1 Jiling Liao  2  3  4 Dong-Il Kim  1  4
Affiliations
  • 1. Department of Physiology, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.
  • 2. Gerontology Department, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • 3. Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • 4. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Abstract

We previously reported the involvement of protein arginine methyltransferase 1 (PRMT1) in adipocyte thermogenesis. Here, we investigate the effects of PRMT1 inhibitors on thermogenesis. Unexpectedly, we find that the PRMT1 Inhibitor TC-E 5003 (TC-E) induces the thermogenic properties of primary murine and human subcutaneous adipocytes. TC-E treatment upregulates the expression of Ucp1 and Fgf21 significantly and activates protein kinase A signaling and lipolysis in primary subcutaneous adipocytes from both mouse and humans. We further find that the thermogenic effects of TC-E are independent of PRMT1 and beta-adrenergic receptors. Our data indicate that TC-E exerts strong effects on murine and human subcutaneous adipocytes by activating beige adipocytes via PKA signaling.

Keywords
PKA; PRMT1; UCP1; lipolysis; thermogenesis.
Products